Favorable dynamic are intact, including demographic trend and increased use of generics.
Drug Retail and other related groups could be poised to ride the rising tide of prescription drug spending.
At a time when our Group Selection Scores have been deteriorating among the various Pharmaceutical groups tracked, our numbers for the Generic Pharma group have improved to the point where the group is now rated Attractive.
Injecting small starter position of Generic Pharmaceuticals into the Select Industries Portfolio, bringing exposure to Health Care sector to a modest overweight position.
Health Care was our top-ranked sector from March 2003 to February 2004. Since that time, the sector’s composite score has steadily fallen.
The near term is becoming more uncertain for Health Care stocks, as HC groups have experienced an erosion in GS Score strength.
Upgraded to Attractive for October as a result of three consecutive months of rising quantitative scores.
Eliminating six groups and adding four to our Equity Strategies product next month. Components and methodologies explained.